Search research articles
Contact Us
Filters
Showing results (31-40 of 87) with videos related to
Page
of 9
Sort By:
The American Journal of Surgical Pathology
|
August 18, 2017
Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived From Centrocytes in the Germinal Center
Xin Li, Zijun Y Xu-Monette, Shuhua Yi, et al.
Blood
|
September 28, 2019
Ublituximab and umbralisib in relapsed/refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia
Matthew Lunning, Julie Vose, Loretta Nastoupil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 8, 2013
Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma
Yasuhiro Oki, Daniela Buglio, Michelle Fanale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2011
Bortezomib, bendamustine, and rituximab in patients with relapsed or refractory follicular lymphoma: the phase II VERTICAL study
Nathan Fowler, Brad S Kahl, Peter Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 3, 2017
Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOP
Paolo Strati, Nathan Fowler, Sergio Pina-Oviedo, et al.
British Journal of Haematology
|
July 22, 2014
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma
Jason R Westin, Peter McLaughlin, Jorge Romaguera, et al.
British Journal of Haematology
|
July 22, 2014
90Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease
Felipe Samaniego, Zuzana Berkova, Jorge E Romaguera, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 1, 2015
Outcomes After Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma With Bulky Disease
Jay P Reddy, Mani Akhtari, Grace L Smith, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 21, 2013
Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment
Seema Rawal, Fuliang Chu, Min Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 14, 2020
A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma
Penny Fang, Jillian R Gunther, Chelsea C Pinnix, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 87) with videos related to
Sort By:
Page
of 9
The American Journal of Surgical Pathology
|
August 18, 2017
Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived From Centrocytes in the Germinal Center
Xin Li, Zijun Y Xu-Monette, Shuhua Yi, et al.
Blood
|
September 28, 2019
Ublituximab and umbralisib in relapsed/refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia
Matthew Lunning, Julie Vose, Loretta Nastoupil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 8, 2013
Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma
Yasuhiro Oki, Daniela Buglio, Michelle Fanale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2011
Bortezomib, bendamustine, and rituximab in patients with relapsed or refractory follicular lymphoma: the phase II VERTICAL study
Nathan Fowler, Brad S Kahl, Peter Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 3, 2017
Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOP
Paolo Strati, Nathan Fowler, Sergio Pina-Oviedo, et al.
British Journal of Haematology
|
July 22, 2014
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma
Jason R Westin, Peter McLaughlin, Jorge Romaguera, et al.
British Journal of Haematology
|
July 22, 2014
90Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease
Felipe Samaniego, Zuzana Berkova, Jorge E Romaguera, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 1, 2015
Outcomes After Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma With Bulky Disease
Jay P Reddy, Mani Akhtari, Grace L Smith, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 21, 2013
Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment
Seema Rawal, Fuliang Chu, Min Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 14, 2020
A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma
Penny Fang, Jillian R Gunther, Chelsea C Pinnix, et al.
Page
of 9